LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients

By sjmartinez • July 5, 2022

Altinbas A, Holmes JA, Salloum S, Lidofsky A, Alatrakchi N, Somsouk M, Hunt P, Deeks S, Chew KW, Lauer G, Kruger A, Lin W, Chung RT. LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients. Biomark Med. 2022 Aug;16(11):839-846. doi: 10.2217/bmm-2021-0596. Epub 2022 Jul 5. PMID: 35786977.

Tags: antiretroviral therapy, hepatitis C virus infection, HIV infection, Infectious Diseases, liver fibrosis, LOXL-2, peginterferon and ribavirin therapy, Publications, TNC-C

Rare mycetoma caused by Raghukumaria species, a mangrove-derived dematiaceous fungus in a kidney transplant patient

Gonzalez-Ferrer S, Yanagimoto-Ogawa L, Zhuo R, Matysiak Match CJ, Dayo A, Kang Y, Yang S. Rare mycetoma caused by Raghukumaria species, a mangrove-derived dematiaceous fungus in a[...]

Cannabis use, risk of cannabis use disorder, and anxiety and depression among bisexual patients: A comparative study of sex and sexual identity differences in a large health system

Setrakian N, Gelberg L, Koerber J, Chung UY, Akabike WN, Gorbach PM, Seamans MJ, Shoptaw S, Cerezo A, Javanbakht M. Cannabis use, risk of cannabis[...]

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.